Group 1 - The core viewpoint of the article highlights the financial status and operational structure of Opcon Vision, including significant share pledges and revenue breakdowns for 2024 [1] - As of the announcement date, Nanjing Outo has pledged approximately 68.3 million shares, accounting for 67.98% of its total holdings [1] - The projected revenue composition for Opcon Vision in 2024 is as follows: 56.18% from the rigid contact lens industry, 20.04% from the medical sector, 19.47% from other optometry and professional services, and 4.31% from non-optometry and other services [1] - The current market capitalization of Opcon Vision is 15.3 billion yuan [1]

Group 1 - The stock price of Oupankangshi on July 30 was 18.12 yuan, a decrease of 0.08 yuan, representing a decline of 0.44% from the previous trading day [1] - The trading volume on that day was 258,927 hands, with a total transaction amount of 472 million yuan [1] - As of July 18, 2025, the total number of shareholders for Oupankangshi was 62,918 [1] Group 2 - The company's main business involves the research, development, production, and sales of ophthalmic medical devices [1] - Key products include orthokeratology lenses and rigid gas permeable contact lenses [1] - On July 30, the net inflow of main funds was 5.5334 million yuan [1]